(Alliance News) - Stock prices in London were still in the green at midday on Thursday, during a week in which China has been "the talk of the town". Read More
(Alliance News) - AstraZeneca PLC on Thursday said that its cancer drug Tagrisso has been approved in the US for certain type of lung cancer. Read More
(Alliance News) - A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the UK's Court of Appeal. Read More
(Alliance News) - AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow this month to hopes for the product. Read More
(Alliance News) - Stocks in London are to open higher on Monday, ahead of flash composite purchasing managers' index data from the US, the UK and mainland Europe. Read More
(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. Read More
(Alliance News) - Stock prices in London went into Wednesday's afternoon on weaker footing, with trade tepid ahead of the evening's Federal Reserve decision, which is on a knife-edge. Read More
(Alliance News) - AstraZeneca PLC on Wednesday announced Fasenra has been approved in the US to treat adult patients with eosinophilic granulomatosis with polyangiitis, or EGPA. Read More
(Alliance News) - The FTSE 100 is called to open lower on Wednesday, as investors digest a UK inflation reading, and look ahead to a US interest rate decision later. Read More
(Alliance News) - AstraZeneca PLC on Monday said that Imfinzi plus Imjudo showed a clinically meaningful overall survival benefit for patients with a form of liver cancer. Read More
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday reported "substantial clinical activity" for Enhertu in a recent clinical trial. Read More
(Alliance News) - Shares in London ended the week on the front foot, as markets priced in rising speculation that the Federal Reserve could yet deliver a bigger-than-expected rate cut next week. Read More
(Alliance News) - London's FTSE 100 held modest gains at midday on Friday as mining stock strength offset further falls for index heavyweight, AstraZeneca. Read More
(Alliance News) - London's FTSE 100 opened a touch higher on Friday, adding to its weekly gains, with gold miners among those in the green in early trade, though AstraZeneca fell after a downbeat broker assessment. Read More
(Alliance News) - London's FTSE 100 is called to open a touch higher, with more strong trade in New York adding some cautious confidence to markets on this side of the Atlantic. Read More
(Alliance News) - London's FTSE 100 underperformed European peers, but headed into Wednesday afternoon just about in the green as a US inflation reading looms. Read More
(Alliance News) - European stocks slid on Tuesday with a double-digit fall in BMW knocking Frankfurt and declines for index heavyweights AstraZeneca, BP and Shell weighing on London. Read More
(Alliance News) - London's FTSE 100 traded lower on Tuesday, underperforming European peers, as index heavyweights in pharmaceuticals, mining, and oil were in the red. Read More
(Alliance News) - London's FTSE 100 started the day on the back foot, returning some of its advance from the start of the week, ahead of US data and a presidential debate across the Atlantic. Read More
